Predicting the Clinical Response to Omalizumab With Anti-IgE Response or Syk Expression in Basophils
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Omalizumab (Primary)
- Indications Allergic asthma
- Focus Biomarker; Pharmacodynamics
- 09 Dec 2017 Status changed from recruiting to completed.
- 08 Jan 2014 New trial record